Successful treatment of necrobiosis lipoidica and associated retinal vasculitis with tumor necrosis factor (TNF)-alpha inhibitor

Purpose: To report the clinical and histopathologic features of necrobiosis lipoidica and associated retinal vasculitis and describe successful treatment of both skin and eye manifestations with adalimumab, a tumor necrosis factor (TNF)-alpha inhibitor. Observations: A 35-year-old patient with bipol...

Full description

Bibliographic Details
Main Authors: Ketaki Panse, Manuela Herrera, Maxwell Fung, Alain Brassard, Kareem Moussa
Format: Article
Language:English
Published: Elsevier 2023-12-01
Series:American Journal of Ophthalmology Case Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2451993623001160
_version_ 1797399097485819904
author Ketaki Panse
Manuela Herrera
Maxwell Fung
Alain Brassard
Kareem Moussa
author_facet Ketaki Panse
Manuela Herrera
Maxwell Fung
Alain Brassard
Kareem Moussa
author_sort Ketaki Panse
collection DOAJ
description Purpose: To report the clinical and histopathologic features of necrobiosis lipoidica and associated retinal vasculitis and describe successful treatment of both skin and eye manifestations with adalimumab, a tumor necrosis factor (TNF)-alpha inhibitor. Observations: A 35-year-old patient with bipolar disorder and ocular hypertension was referred for evaluation of bilateral retinal vasculitis. Fluorescein angiography revealed bilateral occlusive retinal vasculitis. Physical exam was notable for multiple annular and round erythematous hyperpigmented and atrophic patches and plaques on both lower extremities. Skin biopsy revealed a diagnosis of necrobiosis lipoidica, a rare granulomatous skin disease. Both the patient's retinal vasculitis and skin patches responded favorably to treatment with adalimumab, a TNF-alpha inhibitor. Conclusions and importance: This case highlights the importance of obtaining a complete history and physical exam in patients who present with ocular inflammation, as extraocular manifestations of disease may be present. It also demonstrates the effectiveness of a multidisciplinary approach to evaluation and management of these patients, as both skin and eye involvement were successfully treated with adalimumab, a TNF-alpha inhibitor.
first_indexed 2024-03-09T01:34:33Z
format Article
id doaj.art-c344729fead54d6990dcb66ec843bd4e
institution Directory Open Access Journal
issn 2451-9936
language English
last_indexed 2024-03-09T01:34:33Z
publishDate 2023-12-01
publisher Elsevier
record_format Article
series American Journal of Ophthalmology Case Reports
spelling doaj.art-c344729fead54d6990dcb66ec843bd4e2023-12-09T06:07:12ZengElsevierAmerican Journal of Ophthalmology Case Reports2451-99362023-12-0132101908Successful treatment of necrobiosis lipoidica and associated retinal vasculitis with tumor necrosis factor (TNF)-alpha inhibitorKetaki Panse0Manuela Herrera1Maxwell Fung2Alain Brassard3Kareem Moussa4Department of Ophthalmology & Vision Science, University of California, Davis, Sacramento, CA, USAUniversity of California, Davis, School of Medicine, Sacramento, CA, USADepartment of Dermatology, University of California, Davis, Sacramento, CA, USADepartment of Dermatology, University of California, Davis, Sacramento, CA, USADepartment of Ophthalmology & Vision Science, University of California, Davis, Sacramento, CA, USA; Corresponding author. UC Davis Department of Ophthalmology & Vision Science, 4860 Y Street, Ernest E. Tschannen Eye Institute, Sacramento, CA, 95817, USA.Purpose: To report the clinical and histopathologic features of necrobiosis lipoidica and associated retinal vasculitis and describe successful treatment of both skin and eye manifestations with adalimumab, a tumor necrosis factor (TNF)-alpha inhibitor. Observations: A 35-year-old patient with bipolar disorder and ocular hypertension was referred for evaluation of bilateral retinal vasculitis. Fluorescein angiography revealed bilateral occlusive retinal vasculitis. Physical exam was notable for multiple annular and round erythematous hyperpigmented and atrophic patches and plaques on both lower extremities. Skin biopsy revealed a diagnosis of necrobiosis lipoidica, a rare granulomatous skin disease. Both the patient's retinal vasculitis and skin patches responded favorably to treatment with adalimumab, a TNF-alpha inhibitor. Conclusions and importance: This case highlights the importance of obtaining a complete history and physical exam in patients who present with ocular inflammation, as extraocular manifestations of disease may be present. It also demonstrates the effectiveness of a multidisciplinary approach to evaluation and management of these patients, as both skin and eye involvement were successfully treated with adalimumab, a TNF-alpha inhibitor.http://www.sciencedirect.com/science/article/pii/S2451993623001160Occlusive retinal vasculitisNecrobiosis lipoidicaTumor necrosis factor-alpha inhibitorUveitis
spellingShingle Ketaki Panse
Manuela Herrera
Maxwell Fung
Alain Brassard
Kareem Moussa
Successful treatment of necrobiosis lipoidica and associated retinal vasculitis with tumor necrosis factor (TNF)-alpha inhibitor
American Journal of Ophthalmology Case Reports
Occlusive retinal vasculitis
Necrobiosis lipoidica
Tumor necrosis factor-alpha inhibitor
Uveitis
title Successful treatment of necrobiosis lipoidica and associated retinal vasculitis with tumor necrosis factor (TNF)-alpha inhibitor
title_full Successful treatment of necrobiosis lipoidica and associated retinal vasculitis with tumor necrosis factor (TNF)-alpha inhibitor
title_fullStr Successful treatment of necrobiosis lipoidica and associated retinal vasculitis with tumor necrosis factor (TNF)-alpha inhibitor
title_full_unstemmed Successful treatment of necrobiosis lipoidica and associated retinal vasculitis with tumor necrosis factor (TNF)-alpha inhibitor
title_short Successful treatment of necrobiosis lipoidica and associated retinal vasculitis with tumor necrosis factor (TNF)-alpha inhibitor
title_sort successful treatment of necrobiosis lipoidica and associated retinal vasculitis with tumor necrosis factor tnf alpha inhibitor
topic Occlusive retinal vasculitis
Necrobiosis lipoidica
Tumor necrosis factor-alpha inhibitor
Uveitis
url http://www.sciencedirect.com/science/article/pii/S2451993623001160
work_keys_str_mv AT ketakipanse successfultreatmentofnecrobiosislipoidicaandassociatedretinalvasculitiswithtumornecrosisfactortnfalphainhibitor
AT manuelaherrera successfultreatmentofnecrobiosislipoidicaandassociatedretinalvasculitiswithtumornecrosisfactortnfalphainhibitor
AT maxwellfung successfultreatmentofnecrobiosislipoidicaandassociatedretinalvasculitiswithtumornecrosisfactortnfalphainhibitor
AT alainbrassard successfultreatmentofnecrobiosislipoidicaandassociatedretinalvasculitiswithtumornecrosisfactortnfalphainhibitor
AT kareemmoussa successfultreatmentofnecrobiosislipoidicaandassociatedretinalvasculitiswithtumornecrosisfactortnfalphainhibitor